Oblong (OBLG) 10-Q 10 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Nov. 09, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-35376
Entity Registrant Name	OBLONG, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0312442
Entity Address, Address Line One	25587 Conifer Road
Entity Address, Address Line Two	Suite 105-231
Entity Address, City or Town	Conifer
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80433
City Area Code	303
Local Phone Number	640-3838
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	OBLG
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		30,816,048
Entity Central Index Key	0000746210
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 10,734	$ 5,058
Restricted cash	61	158
Accounts receivable, net	1,276	3,166
Inventory	1,856	920
Prepaid expenses and other current assets	1,442	691
Total current assets	15,369	9,993
Property and equipment, net	198	573
Goodwill	7,367	7,367
Intangibles, net	8,142	10,140
Operating lease - right of use asset, net	531	903
Other assets	91	167
Total assets	31,698	29,143
Current liabilities:
Current portion of long-term debt	0	2,014
Accounts payable	538	313
Accrued expenses and other current liabilities	990	1,201
Current portion of deferred revenue	956	1,217
Current portion of operating lease liabilities	475	830
Total current liabilities	2,959	5,575
Long-term liabilities:
Long-term debt, net of current portion	0	403
Operating lease liabilities, net of current portion	182	602
Deferred revenue, net of current portion	412	506
Total long-term liabilities	594	1,511
Total liabilities	3,553	7,086
Commitments and contingencies (see Note 12)
Stockholders’ equity:
Common stock, $.0001 par value; 150,000,000 shares authorized; 30,929,331 shares issued and 30,816,048 outstanding at September 30, 2021 and 7,861,912 shares issued and 7,748,629 outstanding at December 31, 2020	3	1
Treasury stock, 113,283 shares of common stock at September 30, 2021 and December 31, 2020	(181)	(181)
Additional paid-in capital	227,519	215,092
Accumulated deficit	(199,196)	(192,855)
Total stockholder's equity	28,145	22,057
Total liabilities and stockholders’ equity	31,698	29,143
Series A-2 Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series D Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series E Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Preferred stock, convertible, shares authorized (in shares)	5,000,000
Preferred stock, convertible, shares issued (in shares)	0
Preferred stock, convertible, shares outstanding (in shares)	0	1,829,582
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	30,929,331	7,861,912
Common stock, shares outstanding (in shares)	30,816,048	7,748,629
Treasury stock, shares (in shares)	113,283	113,283
Series A-2 Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 7,500	$ 7,500
Preferred stock, convertible, shares authorized (in shares)	7,500	7,500
Preferred stock, convertible, shares issued (in shares)	0	45
Preferred stock, convertible, shares outstanding (in shares)	0	45
Series D Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 28.50	$ 28.50
Preferred stock, convertible, shares authorized (in shares)	1,750,000	1,750,000
Preferred stock, convertible, shares issued (in shares)	0	1,697,958
Preferred stock, convertible, shares outstanding (in shares)	0	1,697,958
Series E Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 28.50	$ 28.50
Preferred stock, convertible, shares authorized (in shares)	175,000	175,000
Preferred stock, convertible, shares issued (in shares)	0	131,579
Preferred stock, convertible, shares outstanding (in shares)	0	131,579

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue	$ 1,799	$ 3,266	$ 5,766	$ 11,410
Cost of revenue (exclusive of depreciation and amortization)	1,228	1,612	3,767	5,684
Gross profit	571	1,654	1,999	5,726
Operating expenses:
Research and development	693	747	1,984	3,062
Sales and marketing	438	668	1,537	2,708
General and administrative	1,628	1,332	5,078	5,173
Impairment charges	254	117	302	667
Depreciation and amortization	669	780	2,098	2,392
Total operating expenses	3,682	3,644	10,999	14,002
Loss from operations	(3,111)	(1,990)	(9,000)	(8,276)
Interest and other expense, net	2	95	16	322
Other income	(3)	0	(227)	0
Gain on extinguishment of debt	(2,448)	0	(2,448)	0
Interest and other (income) expense, net	(2,449)	95	(2,659)	322
Loss before income taxes	(662)	(2,085)	(6,341)	(8,598)
Income tax expense	0	0	0	0
Net loss	(662)	(2,085)	(6,341)	(8,598)
Preferred stock dividends	0	4	1	12
Less: undeclared dividends	0	0	366	0
Induced conversion of Series A-2 Preferred Stock	0	0	300	0
Net loss attributable to common stockholders	(662)	(2,089)	(7,008)	(8,610)
Net loss attributable to common stockholders	$ (662)	$ (2,089)	$ (7,008)	$ (8,610)
Net loss attributable to common stockholders per share:
Basic net loss per share (in dollars per share)	$ (0.02)	$ (0.40)	$ (0.28)	$ (1.64)
Diluted net loss per share (in dollars per share)	$ (0.02)	$ (0.40)	$ (0.28)	$ (1.64)
Weighted-average number of shares of common stock:
Basic (in shares)	30,739,000	5,257,000	25,121,000	5,237,000
Diluted (in shares)	30,739,000	5,257,000	25,121,000	5,237,000

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)	Total	Series D and E Preferred Stock	Preferred StockSeries A-2 Preferred Stock	Preferred StockSeries C Preferred Stock	Preferred StockSeries D Preferred Stock	Preferred StockSeries E Preferred Stock	Common Stock	Common StockSeries A-2 Preferred Stock	Common StockSeries D and E Preferred Stock	Treasury Stock	Additional Paid-In Capital	Additional Paid-In CapitalSeries D and E Preferred Stock	Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2019			32	475	1,734,901	131,579	5,266,828			105,285
Beginning Balance at Dec. 31, 2019	$ 21,785,000		$ 0	$ 0	$ 0	$ 0	$ 1,000			$ (165,000)	$ 207,383,000		$ (185,434,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,129,000)												(3,129,000)
Stock-based compensation	32,000										32,000
Preferred stock conversion (in shares)				(150)			50,000
Issuance of preferred stock for accrued dividends (in shares)			13
Issuance of preferred stock for accrued dividends	98,000										98,000
Forfeited restricted stock (in shares)					(14,441)
Preferred stock dividends	(4,000)										(4,000)
Purchase of treasury stock	(7,000)									$ (7,000)
Ending Balance (in shares) at Mar. 31, 2020			45	325	1,720,460	131,579	5,316,828			105,285
Ending Balance at Mar. 31, 2020	18,775,000		$ 0	$ 0	$ 0	$ 0	$ 1,000			$ (172,000)	207,509,000		(188,563,000)
Beginning Balance (in shares) at Dec. 31, 2019			32	475	1,734,901	131,579	5,266,828			105,285
Beginning Balance at Dec. 31, 2019	21,785,000		$ 0	$ 0	$ 0	$ 0	$ 1,000			$ (165,000)	207,383,000		(185,434,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(8,598,000)
Preferred stock conversion (in shares)							75,000
Ending Balance (in shares) at Sep. 30, 2020			45	250	1,702,010	131,579	5,355,841			113,283
Ending Balance at Sep. 30, 2020	13,345,000		$ 0	$ 0	$ 0	$ 0	$ 1,000			$ (181,000)	207,558,000		(194,033,000)
Beginning Balance (in shares) at Dec. 31, 2019			32	475	1,734,901	131,579	5,266,828			105,285
Beginning Balance at Dec. 31, 2019	21,785,000		$ 0	$ 0	$ 0	$ 0	$ 1,000			$ (165,000)	207,383,000		(185,434,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation										$ (16,000)
Series D Preferred Stock exchanged for taxes (in shares)										(8,000)
Ending Balance (in shares) at Dec. 31, 2020			45		1,697,958	131,579	7,861,912			113,283
Ending Balance at Dec. 31, 2020	22,057,000		$ 0		$ 0	$ 0	$ 1,000			$ (181,000)	215,092,000		(192,855,000)
Beginning Balance (in shares) at Mar. 31, 2020			45	325	1,720,460	131,579	5,316,828			105,285
Beginning Balance at Mar. 31, 2020	18,775,000		$ 0	$ 0	$ 0	$ 0	$ 1,000			$ (172,000)	207,509,000		(188,563,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,385,000)												(3,385,000)
Stock-based compensation	29,000										29,000
Issuance of preferred stock for accrued dividends	1,000										1,000
Forfeited restricted stock (in shares)					(17,364)
Issuance of restricted stock (in shares)							23,334
Preferred stock dividends	(4,000)										(4,000)
Purchase of treasury stock (in shares)										7,998
Purchase of treasury stock	(9,000)									$ (9,000)
Ending Balance (in shares) at Jun. 30, 2020			45	325	1,703,096	131,579	5,340,162			113,283
Ending Balance at Jun. 30, 2020	15,407,000		$ 0	$ 0	$ 0	$ 0	$ 1,000			$ (181,000)	207,535,000		(191,948,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,085,000)												(2,085,000)
Stock-based compensation	27,000										27,000
Preferred stock conversion (in shares)				(75)			25,000
Forfeited restricted stock (in shares)					(1,086)		(9,321)
Preferred stock dividends	(4,000)										(4,000)
Ending Balance (in shares) at Sep. 30, 2020			45	250	1,702,010	131,579	5,355,841			113,283
Ending Balance at Sep. 30, 2020	13,345,000		$ 0	$ 0	$ 0	$ 0	$ 1,000			$ (181,000)	207,558,000		(194,033,000)
Beginning Balance (in shares) at Dec. 31, 2020			45		1,697,958	131,579	7,861,912			113,283
Beginning Balance at Dec. 31, 2020	22,057,000		$ 0		$ 0	$ 0	$ 1,000			$ (181,000)	215,092,000		(192,855,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,433,000)												(3,433,000)
Stock-based compensation	33,000										33,000
Preferred stock conversion (in shares)			(45)		(1,697,022)	(131,579)		84,292	18,762,119
Preferred stock conversion		$ 0							$ 2,000			$ (2,000)
Issuance of stock for services (in shares)							21,008
Issuance of stock for services	274,000										274,000
Forfeited restricted stock (in shares)					(81)
Series D Preferred Stock exchanged for taxes (in shares)					(855)
Ending Balance (in shares) at Mar. 31, 2021			0		0	0	26,729,331			113,283
Ending Balance at Mar. 31, 2021	18,931,000		$ 0		$ 0	$ 0	$ 3,000			$ (181,000)	215,397,000		(196,288,000)
Beginning Balance (in shares) at Dec. 31, 2020			45		1,697,958	131,579	7,861,912			113,283
Beginning Balance at Dec. 31, 2020	22,057,000		$ 0		$ 0	$ 0	$ 1,000			$ (181,000)	215,092,000		(192,855,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(6,341,000)
Preferred stock conversion (in shares)							18,846,411
Ending Balance (in shares) at Sep. 30, 2021			0		0	0	30,929,331			113,283
Ending Balance at Sep. 30, 2021	28,145,000		$ 0		$ 0	$ 0	$ 3,000			$ (181,000)	227,519,000		(199,196,000)
Beginning Balance (in shares) at Mar. 31, 2021			0		0	0	26,729,331			113,283
Beginning Balance at Mar. 31, 2021	18,931,000		$ 0		$ 0	$ 0	$ 3,000			$ (181,000)	215,397,000		(196,288,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,246,000)												(2,246,000)
Issuance of stock from financing, net of issuance costs (in shares)							4,000,000
Issuance of stock from financing, net of issuance costs	11,504,000										11,504,000
Issuance of stock for services	116,000										116,000
Ending Balance (in shares) at Jun. 30, 2021			0		0	0	30,729,331			113,283
Ending Balance at Jun. 30, 2021	28,305,000		$ 0		$ 0	$ 0	$ 3,000			$ (181,000)	227,017,000		(198,534,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(662,000)												(662,000)
Stock-based compensation	502,000										502,000
Issuance of stock on vested restricted stock units							$ 200,000
Ending Balance (in shares) at Sep. 30, 2021			0		0	0	30,929,331			113,283
Ending Balance at Sep. 30, 2021	$ 28,145,000		$ 0		$ 0	$ 0	$ 3,000			$ (181,000)	$ 227,519,000		$ (199,196,000)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (6,341)	$ (8,598)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,098	2,392
Bad debt expense	280	14
Amortization of debt discount	0	53
Amortization of right of use asset	372	834
Stock-based compensation	535	89
Stock-based expense for services	390	0
Gain on extinguishment of lease liability	(227)	0
Gain on extinguishment of debt	(2,448)	0
Impairment charges - property and equipment	98	126
Impairment charges - intangible assets	207	0
Impairment charges - goodwill	0	541
Changes in operating assets and liabilities:
Accounts receivable	1,610	322
Inventory	(936)	689
Prepaid expenses and other current assets	(751)	240
Other assets	15	(32)
Accounts payable	225	15
Accrued expenses and other current liabilities	11	(184)
Deferred revenue	(355)	72
Lease liabilities	(739)	(895)
Other liabilities	0	(3)
Net cash used in operating activities	(5,956)	(4,325)
Cash flows from investing activities:
Purchases of property and equipment	(30)	(8)
Net cash used in investing activities	(30)	(8)
Cash flows from financing activities:
Proceeds from stock issuance, net of issuance costs	11,504	0
Proceeds from PPP Loan	0	2,417
Purchase of treasury stock	0	(16)
Net cash provided by financing activities	11,504	2,401
Increase (decrease) in cash and restricted cash	5,518	(1,932)
Cash and restricted cash at beginning of period	5,277	4,602
Cash and restricted cash at end of period	10,795	2,670
Reconciliation of cash and restricted cash
Cash	10,734	2,670
Restricted cash	61	0
Total cash and restricted cash	10,795	2,670
Cash paid during the period for interest	3	159
Non-cash investing and financing activities:
Issuance of preferred stock in exchange for accrued dividends	0	99
Accrued preferred stock dividends	1	12
Inducement to convert Series A-2 Preferred Stock to common	300	0
Common stock issued for conversion of preferred stock	$ 3	$ 0

Business Description and Signif

Business Description and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Business Description and Significant Accounting Policies	Business Description and Significant Accounting Policies Business Description Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications. Prior to March 6, 2020, Oblong, Inc. was named Glowpoint, Inc. (“Glowpoint”). On March 6, 2020, Glowpoint changed its name to Oblong, Inc. Basis of Presentation The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2020. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2020 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2020 and notes thereto included in the Company's fiscal 2020 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 30, 2021 (the “2020 10-K”). The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. Principles of Consolidation The condensed consolidated financial statements include the accounts of Oblong and our 100%-owned subsidiaries, (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, (ii) Oblong Industries, and (iii) the following subsidiaries of Oblong Industries: Oblong Industries Europe, S.L. and Oblong Europe Limited. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries. Segments The Company currently operates in two segments: 1) the Oblong (formerly Glowpoint) business, which includes managed services for video collaboration and network applications, and 2) the Oblong Industries business, which includes products and services for visual collaboration technologies. See Note 11 - Segment Reporting for further discussion. Use of Estimates Preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability of property and equipment, and intangible assets, the inputs used in the valuation of goodwill and intangible assets in connection with our impairment tests, and the inputs used in the fair value of equity-based awards as well as the values ascribed to assets acquired and liabilities assumed in the business combination. Significant Accounting Policies The significant accounting policies used in preparation of these condensed consolidated financial statements are disclosed in our 2020 10-K, and there have been no changes to the Company’s significant accounting policies during the nine months ended September 30, 2021. Property and Equipment Property and equipment are stated at cost and are depreciated over the estimated useful lives of the related assets, which range from three Recently Issued Accounting Pronouncements In June 2016 the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13 as amended, “Financial Instruments - Credit Losses (Topic 326).” Topic 326 introduces an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., accounts receivable, loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. Topic 326 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact the new guidance will have on its consolidated financial statements. In May 2021, the FASB issued ASU 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. The FASB is issuing this update to clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity classified written call options (for example, warrants) that remain equity classified after modification or exchange. ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring after the effective date of the amendments. The Company does not expect this update to have a material effect on its consolidated financial statements.

Liquidity and Going Concern Unc

Liquidity and Going Concern Uncertainty	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity and Going Concern Uncertainty	Liquidity and Going Concern Uncertainty As of September 30, 2021, we had $10,734,000 of unrestricted cash and working capital of $12,410,000. For the nine months ended September 30, 2021, we incurred a net loss of $6,341,000 and used $5,956,000 of net cash in operating activities. Our capital requirements in the future will continue to depend on numerous factors, including the timing and amount of revenue for the Company, customer renewal rates and the timing of collection of outstanding accounts receivable, in each case particularly as it relates to the Company’s major customers, the expense to deliver services, expense for sales and marketing, expense for research and development, capital expenditures, and the cost involved in protecting intellectual property rights. While our acquisition of Oblong Industries provides additional revenues to the Company, the cost to further develop and commercialize Oblong Industries’ product offerings is expected to exceed its revenues for the foreseeable future. We expect to continue to invest in product development and sales and marketing expenses with the goal of growing the Company’s revenue in the future. The Company believes that, based on the Company’s current projection of revenue, expenses, capital expenditures, and cash flows, it will not have sufficient resources to fund its operations for the next twelve months following the filing of this Report. We believe additional capital will be required to fund operations and provide growth capital including investments in technology, product development and sales and marketing. To access capital to fund operations or provide growth capital, we will need to raise capital in one or more debt and/or equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The factors discussed above raise substantial doubt as to our ability to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments that might result from these uncertainties. See Note 12 - Commitments and Contingencies to our condensed consolidated financial statements for discussion regarding certain additional factors that could impact the Company’s liquidity in the future.

Goodwill

Goodwill	9 Months Ended
	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill As of September 30, 2021 and December 31, 2020, goodwill was $7,367,000, recorded in connection with the October 1, 2019 acquisition of Oblong Industries. All goodwill as of September 30, 2021 and December 31, 2020 is recorded within the Oblong Industries reporting unit. We test goodwill for impairment on an annual basis on September 30 of each year, or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. The Company operates two reporting segments, Oblong (formerly Glowpoint) and Oblong Industries. To determine the fair value of each reporting unit as of September 30, 2021 for the goodwill impairment test, we used a weighted average of the discounted cash flow method and a market-based method. The fair value of the Oblong Industries reporting unit exceeded its carrying amount, therefore no impairment charge on goodwill was recorded. In the event we experience future declines in our revenue, cash flows and/or stock price, this may give rise to a triggering event that may require the Company to record impairment charges on goodwill in the future.

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets The following table presents the components of net intangible assets (in thousands): As of September 30, 2021 As of December 31, 2020 Gross Carrying Amount Accumulated Amortization Impairment Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Oblong (formerly Glowpoint) Affiliate network $ 994 $ (787) $ (207) $ — $ 994 $ (735) $ 259 Oblong Industries Developed technology $ 10,060 $ (4,032) $ — $ 6,028 $ 10,060 $ (2,520) $ 7,540 Trade names 2,410 (482) $ — 1,928 2,410 (302) 2,108 Distributor relationships 310 (124) $ — 186 310 (77) 233 Subtotal 12,780 (4,638) $ — 8,142 12,780 (2,899) 9,881 Total $ 13,774 $ (5,425) $ (207) $ 8,142 $ 13,774 $ (3,634) $ 10,140 At each reporting period, we determine if there was a triggering event that may result in an impairment of our intangible assets. Oblong Industries Reportable Segment During the three months ended September 30, 2021, we considered the decline in revenue for Oblong Industries to be a triggering event for a recoverability test of intangible assets for this reporting unit. Based on the corresponding recoverability tests of Oblong Industries’ intangible assets, we determined no impairment charges were required for the three months ended September 30, 2021. Oblong (formerly Glowpoint) Reportable Segment During the three months ended September 30, 2021, Oblong (formerly Glowpoint) stopped offering video meeting suites (“VMS”) services. VMS services were a component of Oblong’s video collaboration services revenue stream and contributed to the cashflows relating to the affiliate network intangible asset. During the three months ended September 30, 2021, we identified the cessation of our VMS services to be a triggering event for a recoverability test of the affiliate network intangible asset. Based on the corresponding recoverability test, we deemed the affiliate network intangible asset to have no remaining value as of September 30, 2021. Therefore, we recorded an impairment charge of $207,000 for the three months ended September 30, 2021. Intangible assets with finite lives are amortized using the straight-line method over the estimated economic lives of the assets, which range from five years to twelve years in accordance with ASC Topic 350. The weighted average economic lives for the components of intangible assets are as follows: Oblong Industries Developed technology 5 years Trade names 10 years Distributor relationships 5 years Related amortization expense was $597,000, $1,791,000, $611,000, and $1,835,000 for the three and nine months ended September 30, 2021 and 2020, respectively. Amortization expense for each of the next five succeeding years will be as follows (in thousands): Remainder of 2021 $ 580 2022 2,316 2023 2,309 2024 1,792 2025 241 Thereafter 904 Total $ 8,142

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Sep. 30, 2021
Other Liabilities Disclosure [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses and other liabilities consisted of the following (in thousands): September 30, December 31, 2021 2020 Accrued compensation costs $ 421 $ 411 Accrued professional fees 208 236 Accrued taxes and regulatory fees 172 137 Customer deposits 51 127 Other accrued expenses and liabilities 138 286 Accrued dividends on Series A-2 Preferred Stock — 4 Accrued expenses and other current liabilities $ 990 $ 1,201

Debt

Debt	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Debt	Debt Debt consisted of the following (in thousands): September 30, December 31, 2021 2020 PPP Loan Principal $ — $ 2,417 Less: current portion of long-term debt — 2,014 Long-term debt, net of current portion $ — $ 403 Paycheck Protection Program Loan On April 10, 2020 (the “Origination Date”), the Company received $2,417,000 in aggregate loan proceeds (the “PPP Loan”) from MidFirst Bank (the “Lender”) pursuant to the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The PPP Loan was evidenced by a Promissory Note (the “Note”), dated April 10, 2020, by and between the Company and the Lender. Subject to the terms of the Note, the PPP Loan bore interest at a fixed rate of one percent (1.0%) per annum. Payments of principal and interest were deferred for the first six months following the Origination Date. The PPP Loan was unsecured and guaranteed by the U.S. Small Business Administration (the “SBA”). The PPP provided for forgiveness of up to the full amount borrowed as long as the Company uses the loan proceeds during the 24-week period following disbursement for eligible purposes as described in the CARES Act and related guidance. On July 28, 2021, the Company received notice that the PPP Loan had been forgiven in its entirety. As of December 31, 2020, the Company accounted for payments that are due within 12 months of the balance sheet date as current liabilities and payments due thereafter as non-current liabilities. As of September 30, 2021, there is no remaining principal balance or accrued interest on the Note due to the forgiveness of the Note received on July 28, 2021. The Company recognized a gain on debt extinguishment of $2,448,000 during the three and nine months ended September 30, 2021, comprised of $2,417,000 of Note principal and $31,000 of accrued interest as of the date of forgiveness.

Capital Stock

Capital Stock	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Capital Stock	Capital Stock Common Stock On February 1, 2021, the Company, acting pursuant to authorization from its Board of Directors, determined to voluntarily withdraw the listing of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), from the NYSE American Stock Exchange (the “NYSE American”) and transfer such listing to The Nasdaq Capital Market (“Nasdaq”). The Company’s listing and trading of its Common Stock on the NYSE American ended at market close on February 11, 2021, and trading began on Nasdaq at market open on February 12, 2021, and is continuing to trade under the ticker symbol “OBLG”. As of September 30, 2021, we had 150,000,000 shares of our Common Stock authorized, with 30,929,331 and 30,816,048 shares issued and outstanding, respectively. During the nine months ended September 30, 2021 and 2020, 18,846,411 and 75,000 shares of the Company’s Common stock were issued in relation to preferred stock conversions, respectively, and 200,000 and 23,334 shares were issued as stock-based compensation, respectively. Issuance for Professional Service Fees On December 10, 2020, the Company issued 50,000 shares of Common Stock as payment for services, with a fair value equal to $348,000, related to a financial advisory agreement entered into on December 1, 2020. On January 21, 2021, the Company issued 21,008 shares of Common Stock as payment for services, with a fair value equal to $100,000, related to a financial advisory agreement entered into on January 15, 2021. During the nine months ended September 30, 2021, the Company recorded stock-based professional services expense of $390,000 relating to the issuance of the shares above, which is included as a component of general and administrative expense in the accompanying condensed consolidated statements of operations. Issuance Pursuant to Equity Financing On June 30, 2021, the Company closed on a concurrent public offering of 4,000,000 shares of Common Stock, Series A Warrants to purchase 1,000,000 shares of the Company’s Common Stock at an exercise price of $4.00 per share, and private placement of Series B Warrants to purchase 3,000,000 shares of common stock at an exercise price of $4.40 per share for gross proceeds of $12,400,000. Issuance costs for this transaction were $896,000, resulting in net proceeds of $11,504,000. Warrants On October 21, 2020, the Company issued warrants to purchase up to 521,500 shares of Common Stock pursuant to a securities purchase agreement with certain accredited investors. The Warrants have a term of 2 years, are initially exercisable at $4.08 per share and are subject to cashless exercise if, at the time of exercise, the Warrant Shares are not subject to an effective resale registration statement. The Warrants are also subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Warrants do not have any price protection or price reset provisions with respect to future issuances of securities. The fair value of the Warrants was recorded to additional paid-in capital during the year ended December 31, 2020. As of September 30, 2021, no warrants had been exercised. On December 6, 2020, the Company issued warrants to purchase up to 625,000 shares of Common Stock pursuant to a securities purchase agreement with certain accredited investors. The Warrants have a term of 2 years, are initially exercisable at $5.49 per share and are subject to cashless exercise if, at the time of exercise, the Warrant Shares are not subject to an effective resale registration statement. The Warrants are also subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Warrants do not have any price protection or price reset provisions with respect to future issuances of securities. The fair value of the Warrants was recorded to additional paid-in capital during the year ended December 31, 2020. As of September 30, 2021, no warrants had been exercised. On June 30, 2021, the Company issued Series A Warrants to purchase up to 1,000,000 shares of Common Stock, and Series B Warrants to purchase up to 3,000,000 shares of Common Stock, pursuant to a securities purchase agreement with certain accredited investors. The Series A Warrants have a term of 6 months and are initially exercisable at $4.00 per share. The Series B Warrants have a term of 3 years, commencing six months and one day from the date of issuance, and are initially exercisable at $4.40 per share. All of the warrants are subject to cashless exercise if, at the time of exercise, the Warrant Shares are not subject to an effective resale registration statement. The Warrants are also subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Warrants do not have any price protection or price reset provisions with respect to future issuances of securities. The fair value of the Series A and B Warrants was recorded to additional paid-in capital during the nine months ended September 30, 2021. As of September 30, 2021, no warrants had been exercised. Warrant activity for the nine months ended September 30, 2021 and the year ended December 31, 2020 is presented below. Outstanding Number of Warrants (in thousands) Weighted Average Exercise Price Warrants outstanding and exercisable, December 31, 2019 72 0.01 Granted 1,147 4.85 Exercised (72) 0.01 Warrants outstanding and exercisable, December 31, 2020 1,147 $ 4.85 Granted 4,000 4.30 Warrants outstanding and exercisable, September 30, 2021 5,147 $ 4.42 Treasury Shares The Company maintains Treasury Stock for the Common Stock shares bought back by the Company when withholding shares to cover taxes on stock compensation transactions. The following table shows the activity for Treasury Stock during the year ended December 31, 2020 (in thousands). There were no treasury stock transactions during the nine months ended September 30, 2021. Shares Value Treasury Shares as of December 31, 2019 105 $ (165) Purchases to cover stock compensation taxes 8 (16) Treasury Shares as of December 31, 2020 113 $ (181) Treasury Shares as of September 30, 2021 113 $ (181)

Preferred Stock

Preferred Stock	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Preferred Stock	Preferred Stock Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of September 30, 2021, we had 1,941,250 designated shares of preferred stock and no shares of preferred stock issued and outstanding. As of December 31, 2020, we had 1,829,582 shares of preferred stock outstanding. Series A-2 Preferred Stock As of December 31, 2020, there were 45 shares of Series A-2 Preferred Stock issued and outstanding. Each share of Series A-2 Preferred Stock had a stated value of $7,500 per share (the “A-2 Stated Value”), a liquidation preference equal to the Series A-2 Stated Value, and was convertible at the holder’s election into common stock at a conversion price per share of $16.11. Therefore, each share of Series A-2 Preferred Stock was convertible into 466 shares of common stock, for an aggregate of 20,954 shares of common stock. The Series A-2 Preferred Stock was senior to all outstanding classes of the Company’s equity and was entitled to cumulative dividends at a rate of 5.0% per annum. As of December 31, 2020, the Company had recorded $4,000 in accrued dividends on the accompanying condensed consolidated Balance Sheets related to the Series A-2 Preferred Stock outstanding. During the nine months ended September 30, 2021, an additional $1,000 dividend was recorded. On January 28, 2021, the Company entered into an agreement with the holder of the Series A-2 Preferred Stock to convert the stated value of all outstanding shares of the Series A-2 Preferred Stock, 45 shares, into 84,292 shares of the Company’s common stock, at a negotiated conversion price of $4.00 per share, after taking into consideration accrued and unpaid dividends. The incremental cost of inducing the conversion was approximately $300,000 and was treated similar to a preferred dividend, increasing the net loss attributable to common stockholders. Series D and E Preferred Stock In connection with the Oblong Industries acquisition, on October 1, 2019 (the “Closing Date”), the Company issued an aggregate of 1,686,659 shares of Series D Preferred Stock and an aggregate of 49,967 restricted shares of Series D Preferred Stock (“Restricted Series D Preferred Stock”), the latter of which were subject to vesting over a two-year period following the Closing Date. Pursuant to the terms of the Series D Certificate of Designations, each share of Series D Preferred Stock was entitled to receive an annual dividend equal to 6.0% of its then-existing Accrued Value per annum, commencing on the first anniversary of the issuance of the Series D Preferred Stock (or October 1, 2020). Prior to the first anniversary of the issuance of the Series D Preferred Stock no dividends accrued on such stock. Dividends were cumulative and accrued daily in arrears. The accrued value of the Series D Preferred Stock was increased by the amount of such dividends from October 1, 2020 through the date of conversion as described below. During the year ended December 31, 2020, 28,618 shares of Restricted Series D Preferred Stock were forfeited and 8,325 shares of Series D Preferred Stock were surrendered to cover the taxes on vesting shares. During the three months ended March 31, 2021, 81 shares of Restricted Series D Preferred Stock were forfeited and 855 shares of Series D Preferred Stock were surrendered to cover the taxes on vesting shares. On October 1, 2019, Oblong entered into a Series E Preferred Stock Purchase Agreement relating to the offer and sale by the Company of up to 131,579 shares of its Series E Preferred Stock at a price of $28.50 per share. The Company sold a total of 131,579 shares of Series E Preferred Stock for net proceeds of approximately $3,750,000. The 131,579 shares of Series E Preferred Stock had an aggregate accrued value of $3,750,000 and upon their conversion would convert at a conversion price of $2.85 per share into 1,315,790 common shares. Pursuant to the terms of the Series E Certificate of Designations, each share of Series E Preferred Stock was entitled to receive an annual dividend equal to 6.0% of its then-existing Accrued Value per annum, commencing on the first anniversary of the issuance of the Series E Preferred Stock (or October 1, 2019 or December 18, 2019, as applicable). Prior to the first anniversary of the issuance of the Series E Preferred Stock no dividends accrued on such stock. Dividends were cumulative and accrue daily in arrears. The accrued value of the Series E Preferred Stock was increased by the amount of such dividends from October 1, 2020 through the date of conversion as described below. The terms of the Company’s Series D and Series E Preferred Stock provided that such shares were automatically convertible into a number of shares of the Company’s Common Stock equal to the accrued value of the preferred shares (initially $28.50), plus any accrued dividends thereon, divided by the conversion price (initially $2.85 per share, subject to specified adjustments) upon the completion of both (i) approval of such conversion by the Company’s stockholders entitled to vote thereon (which occurred on December 19, 2019); and (ii) the receipt of all required authorizations and approval of a new listing application for the Company following the Company’s October 2019 acquisition of Oblong Industries, Inc. from the NYSE American or any such other exchange upon which the Company’s securities are then listed for trading. The Company determined that this conversion condition was completed in its entirety, and the Series D and E Preferred Stock automatically converted to shares of Common Stock pursuant to their terms, effective upon the commencement of trading of the Company’s Common Stock on Nasdaq as described above, on February 12, 2021. As of the date of conversion, the Company had 1,697,022 shares of Series D Preferred Stock and 131,579 shares of Series E Preferred Stock outstanding, respectively. The outstanding shares of Series D and Series E Preferred stock were converted into 17,416,939 and 1,345,180 shares of Common Stock, respectively, after taking into consideration all accrued and unpaid dividends. Following the conversion of the Series A-2, Series D, and Series E Preferred Stock, the Company no longer has shares of Preferred Stock issued and outstanding.

Stock Based Compensation

Stock Based Compensation	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock Based Compensation	Stock Based Compensation 2019 Equity Incentive Plan On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. As of September 30, 2021, the share pool available for new grants under the 2019 Plan is 2,513,500. Stock Options On June 28, 2021, the Company granted 300,000 stock options to certain employees. These options have a term of 10 years, vest equally over 3 years, 1/3 upon each anniversary of the grant date, and have an exercise price of $3.25 per share. Using the Black-Scholes option pricing model, the options were determined to have a fair value of $745,000 which will be expensed ratably over the vesting term. No stock options were granted during the year ended December 31, 2020. The fair value of each stock option granted was estimated using the following weighted average assumptions: June 28, 2021 Risk free interest rate 0.47% Expected maturity 3 years Expected volatility 136% Expected dividend yields — Weighted average grant date fair value per share $2.48 A summary of stock options activity during the nine months ended September 30, 2021 and the year ended December 31, 2020 is presented below: Outstanding Exercisable Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price Options outstanding, December 31, 2019 215,345 $ 12.27 215,345 $ 12.27 Expired (107,845) 4.92 — — Options outstanding, December 31, 2020 107,500 $ 19.64 107,500 $ 19.64 Granted 300,000 3.25 — — Options outstanding, September 30, 2021 407,500 $ 7.57 107,500 $ 19.64 Additional information as of September 30, 2021 is as follows: Outstanding Exercisable Range of price Number Weighted Weighted Number Weighted $0.00 – $10.00 302,500 9.68 $ 3.30 2,500 $ 9.00 $10.01 – $20.00 97,500 1.31 19.32 97,500 19.32 $20.01 – $30.00 2,500 0.68 21.80 2,500 21.80 $30.01 – $40.00 5,000 0.45 30.20 5,000 30.20 407,500 7.51 $ 7.57 107,500 $ 19.64 The intrinsic value of vested options, unvested options and exercised options were not significant for all periods presented. There was $64,000 and zero stock compensation expense, recorded as a component of Research and Development and General and Administrative expense, related to stock options for the three and nine months ended September 30, 2021 and 2020, respectively, and $681,000 remaining as unrecognized stock-based compensation expense for options as of September 30, 2021, which will be recognized over a weighted average period of 2.75 years. Restricted Stock Awards As of September 30, 2021 and 2020, there were 627 unvested restricted stock awards outstanding, with a weighted average grant date price of $15.80. The awards were issued in 2014 and vest over the lesser of ten years, a change in control, or separation from the company. Due to the variability of the vesting, the expense was amortized over an average service period of five years; therefore, there is no stock-based compensation expense for restricted stock awards for the three and nine months ended September 30, 2021 or 2020. Restricted Stock Units On August 18, 2021, the Company granted 200,000 restricted stock units (“RSUs”) to certain board members. These RSUs vested immediately upon issuance. The price per share of the Company’s common stock was $2.19 on the grant date, resulting in a total fair value of $438,000 which was included in general and administrative expense, as stock-based compensation expense, upon issuance. No RSUs were granted during the year ended December 31, 2020 and $6,000 of stock compensation expense was recorded for existing RSUs for the nine months ended September 30, 2020. There was no remaining unrecognized stock-based compensation expense for RSUs at September 30, 2021. As of September 30, 2021, there were no unvested restricted stock units (“RSUs”) outstanding and 28,904 vested RSUs remain outstanding as shares of common stock have not yet been delivered for these units in accordance with the terms of the RSUs. Restricted Series D Preferred Stock In connection with the acquisition of Oblong Industries in 2019, all options to purchase shares of Oblong Industries’ common stock held by existing employees of Oblong Industries were canceled and exchanged for an aggregate of 49,967 shares of Restricted Series D Preferred Stock, which were subject to vesting over a two-year period following the closing date. This vesting period and compensation expense were accelerated, in February 2021, when the Restricted Series D shares were converted to shares of Common Stock. Refer to Note 8 - Preferred Stock for discussion on the conversion of the Series D Restricted Preferred Stock. Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Research and development $ — $ 11 $ 17 $ 39 Sales, general and administrative $ — $ 17 $ 16 $ 44 $ — $ 28 $ 33 $ 83

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at September 30, 2021 and 2020, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant. Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three and nine months ended September 30, 2021 and 2020, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss). The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Numerator: Net loss $ (662) $ (2,085) $ (6,341) $ (8,598) Less: preferred stock dividends — (4) (1) (12) Less: undeclared dividends — — $ (366) $ — Less: loss on induced conversion of Series A-2 Preferred Stock — — $ (300) $ — Net loss attributable to common stockholders $ (662) $ (2,089) $ (7,008) $ (8,610) Denominator: Weighted-average number of shares of common stock for basic and diluted net loss per share 30,739 5,257 25,121 5,237 Basic and diluted net loss per share $ (0.02) $ (0.40) $ (0.28) $ (1.64) The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): Nine Months Ended September 30, 2021 2020 Outstanding stock options 407,500 107,500 Unvested restricted stock awards 627 627 Shares of common stock issuable upon conversion of Series A-2 preferred stock — 15,545 Shares of common stock issuable upon conversion of Series C preferred stock — 83,333 Shares of common stock issuable upon conversion of Series D preferred stock — 17,030,960 Shares of common stock issuable upon conversion of Series E preferred stock — 1,315,790 Warrants 5,146,500 72,394

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting The Company currently operates in two segments: (1) the Oblong (formerly Glowpoint) business, which includes managed services for video collaboration and network applications; and (2) the Oblong Industries business, which includes products and services for visual collaboration technologies. Certain information concerning the Company’s segments for the three and nine months ended September 30, 2021 and 2020 is presented in the following tables (in thousands): Three Months Ended September 30, 2021 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 1,006 $ 793 $ — $ 1,799 Cost of revenues 721 507 — 1,228 Gross profit $ 285 $ 286 $ — $ 571 Gross profit % 28 % 36 % 32 % Allocated operating expenses $ 337 $ 1,717 $ — $ 2,054 Unallocated operating expenses $ — $ — 1,628 1,628 Total operating expenses $ 337 $ 1,717 $ 1,628 $ 3,682 Loss from operations $ (52) $ (1,431) $ (1,628) $ (3,111) Interest and other expense (income), net 2 (3) (2,448) (2,449) Net income (loss) before tax $ (54) $ (1,428) $ 820 $ (662) Income tax $ — $ — $ — $ — Net income (loss) $ (54) $ (1,428) $ 820 $ (662) Nine Months Ended September 30, 2021 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 3,279 $ 2,487 $ — $ 5,766 Cost of revenues 2,293 1,474 — 3,767 Gross profit $ 986 $ 1,013 $ — $ 1,999 Gross profit % 30 % 41 % 35 % Allocated operating expenses $ 527 $ 5,394 $ — $ 5,921 Unallocated operating expenses 5,078 5,078 Total operating expenses $ 527 $ 5,394 $ 5,078 $ 10,999 Income (loss) from operations $ 459 $ (4,381) $ (5,078) $ (9,000) Interest and other expense (income), net 16 (227) (2,448) (2,659) Net income (loss) before tax $ 443 $ (4,154) $ (2,630) $ (6,341) Income tax $ — $ — $ — $ — Net income (loss) $ 443 $ (4,154) $ (2,630) $ (6,341) Three Months Ended September 30, 2020 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 1,324 $ 1,942 $ — $ 3,266 Cost of revenues 893 719 — 1,612 Gross profit $ 431 $ 1,223 $ — $ 1,654 Gross profit % 33 % 63 % 51 % Allocated operating expenses $ 1,187 $ 1,477 $ — $ 2,664 Unallocated operating expenses — — 980 980 Total operating expenses $ 1,187 $ 1,477 $ 980 $ 3,644 Loss from operations $ (756) $ (254) $ (980) $ (1,990) Interest and other expense, net 5 90 — 95 Net loss before taxes $ (761) $ (344) $ (980) $ (2,085) Income tax $ — $ — $ — $ — Net loss $ (761) $ (344) $ (980) $ (2,085) Nine Months Ended September 30, 2020 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 4,741 $ 6,669 $ — $ 11,410 Cost of revenues 2,948 2,736 — 5,684 Gross profit $ 1,793 $ 3,933 $ — $ 5,726 Gross profit % 38 % 59 % 50 % Allocated operating expenses $ 3,398 $ 7,545 $ — $ 10,943 Unallocated operating expenses — — 3,059 3,059 Total operating expenses $ 3,398 $ 7,545 $ 3,059 $ 14,002 Loss from operations $ (1,605) $ (3,612) $ (3,059) $ (8,276) Interest and other expense, net 12 310 — 322 Net loss before tax $ (1,617) $ (3,922) $ (3,059) $ (8,598) Income tax — — — — Net loss (1,617) (3,922) $ (3,059) $ (8,598) Unallocated operating expenses include costs for the three and nine months ended September 30, 2021 and 2020 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses. For the three and nine months ended September 30, 2021 and 2020, there was no material revenue attributable to any individual foreign country. Approximately 1% of foreign revenue is billed in foreign currency and foreign currency gains and losses are not material. Revenue by geographic area is allocated as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Domestic $ 1,035 $ 2,080 $ 3,277 $ 7,536 Foreign 764 1,186 2,489 3,874 $ 1,799 $ 3,266 $ 5,766 $ 11,410 Disaggregated information for the Company’s revenue has been recognized in the accompanying condensed consolidated statements of operations and is presented below according to contract type (in thousands): Three Months Ended September 30, 2021 % of Revenue 2020 % of Revenue Revenue: Oblong (formerly Glowpoint) Video collaboration services $ 179 10 % $ 249 8 % Network services 813 45 % 1,028 31 % Professional and other services 14 1 % 47 1 % Total Oblong (formerly Glowpoint) revenue $ 1,006 56 % $ 1,324 40 % Revenue: Oblong Industries Visual collaboration product offerings $ 771 43 % 1,686 52 % Licensing 22 1 % 256 8 % Total Oblong Industries revenue $ 793 44 % 1,942 60 % Total revenue $ 1,799 100 % $ 3,266 100 % Nine Months Ended September 30, 2021 % of Revenue 2020 % of Revenue Revenue: Oblong (formerly Glowpoint) Video collaboration services $ 700 12 % $ 1,722 15 % Network services 2,524 44 % 2,844 25 % Professional and other services 55 1 % 175 2 % Total Oblong (formerly Glowpoint) revenue $ 3,279 57 % $ 4,741 42 % Revenue: Oblong Industries Visual collaboration product offerings $ 2,406 42 % 4,931 43 % Professional services — — % 898 8 % Licensing 81 1 % 840 7 % Total Oblong Industries revenue $ 2,487 43.13 % 6,669 58 % Total revenue $ 5,766 100 % $ 11,410 100 % The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition and results of operations. Concentration of revenues was as follows: Three Months Ended September 30, 2021 2020 Segment % of Revenue % of Revenue Customer A Oblong (formerly Glowpoint) 37 % 23 % Customer B Oblong Industries — % 20 % Nine Months Ended September 30, 2021 2020 Segment % of Revenue % of Revenue Customer A Oblong (formerly Glowpoint) 35 % 23 % Customer B Oblong Industries — % 27 % Concentration of accounts receivable was as follows: As of September 30, 2021 2020 Segment % of Accounts Receivable % of Accounts Receivable Customer A Oblong (formerly Glowpoint) 17 % 20 % Customer B Oblong (formerly Glowpoint) — % 15 % Customer C Oblong Industries 12 % — % Customer D Oblong Industries 11 % — %

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 12 - Commitments and Contingencies Operating Leases We currently lease three facilities in Los Angeles, California, one facility in Boston, Massachusetts, and one facility in Dallas, Texas, all providing office space. We also lease space in City of Industry, California, providing warehouse space. These leases expire between 2022 and 2023. During 2020, we exited leases in Herndon, Virginia; Atlanta, Georgia; Houston, Texas; London, England, and a warehouse space in Los Angeles, California. In February 2021, we exited an office space lease in Los Altos, California, when the Company elected to not renew the lease. In June 2021, we entered into a settlement agreement with the landlord of our Munich, Germany office space, to exit the lease early in exchange for €125,000. At the time of the settlement, the remaining liability was €316,000, resulting in a gain of €191,000 ($227,000), which is recorded as other income on the condensed consolidated statement of operations during the nine months ended September 30, 2021. We currently occupy two of the facilities in Los Angeles and the warehouse space in City of Industry; we have subleases in place for the third Los Angeles property, the Dallas property, and the Boston property. Lease expenses, net of common charges and sublet proceeds, for the three and nine months ended September 30, 2021 and 2020 were $85,000, $252,000, $267,000, and $915,000, respectively. The Company primarily leases facilities for office and data center space under non-cancellable operating leases for its U.S. and international locations that expire at various dates through 2023. For leases with a term greater than 12 months, the Company recognizes a right-of-use asset and a lease liability based on the present value of lease payments over the lease term. Variable lease payments are not included in the lease payments to measure the lease liability and are expensed as incurred. The Company’s leases have remaining terms of one As the Company's leases do not provide a readily determinable implicit rate, the Company uses the incremental borrowing rate at lease commencement, which was determined using a portfolio approach, based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. Operating lease expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recognized on the balance sheet and the expense for these short-term leases is recognized on a straight-line basis over the lease term. Common area maintenance fees (or CAMs) and other charges related to these leases continue to be expensed as incurred. The following provides balance sheet information related to leases were as follows (in thousands): September 30, 2021 Assets Operating lease, right-of-use asset, net $ 531 Liabilities Current portion of operating lease liabilities $ 475 Operating lease liabilities, net of current portion 182 Total operating lease liabilities $ 657 The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments Remainder of 2021 $ 189 2022 379 2023 116 Total lease payments $ 684 Effect of discounting (27) Total operating lease liabilities $ 657 COVID-19

Related Party

Related Party	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party	Related Party Effective August 16, 2021, Matthew Blumberg was appointed to the Company’s Board of Directors. Mr. Blumberg is the Co-Founder and CEO of Bolster, an on-demand executive talent marketplace that helps accelerate companies’ growth by connecting them with experienced, highly vetted executives for interim, fractional, advisory, project-based or board roles. During the nine months ended September 30, 2021, the Company paid Bolster $31,000 for fractional labor .

Business Description and Sign_2

Business Description and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2020. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2020 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2020 and notes thereto included in the Company's fiscal 2020 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 30, 2021 (the “2020 10-K”).
Principles of Consolidation	Principles of ConsolidationThe condensed consolidated financial statements include the accounts of Oblong and our 100%-owned subsidiaries, (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, (ii) Oblong Industries, and (iii) the following subsidiaries of Oblong Industries: Oblong Industries Europe, S.L. and Oblong Europe Limited. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.
Segments	Segments The Company currently operates in two segments: 1) the Oblong (formerly Glowpoint) business, which includes managed services for video collaboration and network applications, and 2) the Oblong Industries business, which includes products and services for visual collaboration technologies. See Note 11 - Segment Reporting for further discussion.
Use of Estimates	Use of Estimates Preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include
Property and Equipment	Property and Equipment Property and equipment are stated at cost and are depreciated over the estimated useful lives of the related assets, which range from three
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016 the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13 as amended, “Financial Instruments - Credit Losses (Topic 326).” Topic 326 introduces an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., accounts receivable, loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. Topic 326 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact the new guidance will have on its consolidated financial statements. In May 2021, the FASB issued ASU 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. The FASB is issuing this update to clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity classified written call options (for example, warrants) that remain equity classified after modification or exchange. ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring after the effective date of the amendments. The Company does not expect this update to have a material effect on its consolidated financial statements.

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table presents the components of net intangible assets (in thousands): As of September 30, 2021 As of December 31, 2020 Gross Carrying Amount Accumulated Amortization Impairment Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Oblong (formerly Glowpoint) Affiliate network $ 994 $ (787) $ (207) $ — $ 994 $ (735) $ 259 Oblong Industries Developed technology $ 10,060 $ (4,032) $ — $ 6,028 $ 10,060 $ (2,520) $ 7,540 Trade names 2,410 (482) $ — 1,928 2,410 (302) 2,108 Distributor relationships 310 (124) $ — 186 310 (77) 233 Subtotal 12,780 (4,638) $ — 8,142 12,780 (2,899) 9,881 Total $ 13,774 $ (5,425) $ (207) $ 8,142 $ 13,774 $ (3,634) $ 10,140 The weighted average economic lives for the components of intangible assets are as follows: Oblong Industries Developed technology 5 years Trade names 10 years Distributor relationships 5 years
Schedule of Future Amortization Expense	Amortization expense for each of the next five succeeding years will be as follows (in thousands): Remainder of 2021 $ 580 2022 2,316 2023 2,309 2024 1,792 2025 241 Thereafter 904 Total $ 8,142

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2021
Other Liabilities Disclosure [Abstract]
Schedule of Accrued Expenses and Other Liabilities	Accrued expenses and other liabilities consisted of the following (in thousands): September 30, December 31, 2021 2020 Accrued compensation costs $ 421 $ 411 Accrued professional fees 208 236 Accrued taxes and regulatory fees 172 137 Customer deposits 51 127 Other accrued expenses and liabilities 138 286 Accrued dividends on Series A-2 Preferred Stock — 4 Accrued expenses and other current liabilities $ 990 $ 1,201

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Debt consisted of the following (in thousands): September 30, December 31, 2021 2020 PPP Loan Principal $ — $ 2,417 Less: current portion of long-term debt — 2,014 Long-term debt, net of current portion $ — $ 403

Capital Stock (Tables)

Capital Stock (Tables)	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Schedule of Warrants Activity	Warrant activity for the nine months ended September 30, 2021 and the year ended December 31, 2020 is presented below. Outstanding Number of Warrants (in thousands) Weighted Average Exercise Price Warrants outstanding and exercisable, December 31, 2019 72 0.01 Granted 1,147 4.85 Exercised (72) 0.01 Warrants outstanding and exercisable, December 31, 2020 1,147 $ 4.85 Granted 4,000 4.30 Warrants outstanding and exercisable, September 30, 2021 5,147 $ 4.42
Summary of Treasury Stock Activity	The following table shows the activity for Treasury Stock during the year ended December 31, 2020 (in thousands). There were no treasury stock transactions during the nine months ended September 30, 2021. Shares Value Treasury Shares as of December 31, 2019 105 $ (165) Purchases to cover stock compensation taxes 8 (16) Treasury Shares as of December 31, 2020 113 $ (181) Treasury Shares as of September 30, 2021 113 $ (181)

Stock Based Compensation (Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Valuation Assumptions	The fair value of each stock option granted was estimated using the following weighted average assumptions: June 28, 2021 Risk free interest rate 0.47% Expected maturity 3 years Expected volatility 136% Expected dividend yields — Weighted average grant date fair value per share $2.48
Summary of Options Granted, Exercised, Expired and Forfeited	A summary of stock options activity during the nine months ended September 30, 2021 and the year ended December 31, 2020 is presented below: Outstanding Exercisable Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price Options outstanding, December 31, 2019 215,345 $ 12.27 215,345 $ 12.27 Expired (107,845) 4.92 — — Options outstanding, December 31, 2020 107,500 $ 19.64 107,500 $ 19.64 Granted 300,000 3.25 — — Options outstanding, September 30, 2021 407,500 $ 7.57 107,500 $ 19.64
Shares Outstanding and Exercisable, By Exercise Price Range	Additional information as of September 30, 2021 is as follows: Outstanding Exercisable Range of price Number Weighted Weighted Number Weighted $0.00 – $10.00 302,500 9.68 $ 3.30 2,500 $ 9.00 $10.01 – $20.00 97,500 1.31 19.32 97,500 19.32 $20.01 – $30.00 2,500 0.68 21.80 2,500 21.80 $30.01 – $40.00 5,000 0.45 30.20 5,000 30.20 407,500 7.51 $ 7.57 107,500 $ 19.64
Schedule of Compensation Expense	Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Research and development $ — $ 11 $ 17 $ 39 Sales, general and administrative $ — $ 17 $ 16 $ 44 $ — $ 28 $ 33 $ 83

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Numerator: Net loss $ (662) $ (2,085) $ (6,341) $ (8,598) Less: preferred stock dividends — (4) (1) (12) Less: undeclared dividends — — $ (366) $ — Less: loss on induced conversion of Series A-2 Preferred Stock — — $ (300) $ — Net loss attributable to common stockholders $ (662) $ (2,089) $ (7,008) $ (8,610) Denominator: Weighted-average number of shares of common stock for basic and diluted net loss per share 30,739 5,257 25,121 5,237 Basic and diluted net loss per share $ (0.02) $ (0.40) $ (0.28) $ (1.64)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): Nine Months Ended September 30, 2021 2020 Outstanding stock options 407,500 107,500 Unvested restricted stock awards 627 627 Shares of common stock issuable upon conversion of Series A-2 preferred stock — 15,545 Shares of common stock issuable upon conversion of Series C preferred stock — 83,333 Shares of common stock issuable upon conversion of Series D preferred stock — 17,030,960 Shares of common stock issuable upon conversion of Series E preferred stock — 1,315,790 Warrants 5,146,500 72,394

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	Certain information concerning the Company’s segments for the three and nine months ended September 30, 2021 and 2020 is presented in the following tables (in thousands): Three Months Ended September 30, 2021 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 1,006 $ 793 $ — $ 1,799 Cost of revenues 721 507 — 1,228 Gross profit $ 285 $ 286 $ — $ 571 Gross profit % 28 % 36 % 32 % Allocated operating expenses $ 337 $ 1,717 $ — $ 2,054 Unallocated operating expenses $ — $ — 1,628 1,628 Total operating expenses $ 337 $ 1,717 $ 1,628 $ 3,682 Loss from operations $ (52) $ (1,431) $ (1,628) $ (3,111) Interest and other expense (income), net 2 (3) (2,448) (2,449) Net income (loss) before tax $ (54) $ (1,428) $ 820 $ (662) Income tax $ — $ — $ — $ — Net income (loss) $ (54) $ (1,428) $ 820 $ (662) Nine Months Ended September 30, 2021 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 3,279 $ 2,487 $ — $ 5,766 Cost of revenues 2,293 1,474 — 3,767 Gross profit $ 986 $ 1,013 $ — $ 1,999 Gross profit % 30 % 41 % 35 % Allocated operating expenses $ 527 $ 5,394 $ — $ 5,921 Unallocated operating expenses 5,078 5,078 Total operating expenses $ 527 $ 5,394 $ 5,078 $ 10,999 Income (loss) from operations $ 459 $ (4,381) $ (5,078) $ (9,000) Interest and other expense (income), net 16 (227) (2,448) (2,659) Net income (loss) before tax $ 443 $ (4,154) $ (2,630) $ (6,341) Income tax $ — $ — $ — $ — Net income (loss) $ 443 $ (4,154) $ (2,630) $ (6,341) Three Months Ended September 30, 2020 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 1,324 $ 1,942 $ — $ 3,266 Cost of revenues 893 719 — 1,612 Gross profit $ 431 $ 1,223 $ — $ 1,654 Gross profit % 33 % 63 % 51 % Allocated operating expenses $ 1,187 $ 1,477 $ — $ 2,664 Unallocated operating expenses — — 980 980 Total operating expenses $ 1,187 $ 1,477 $ 980 $ 3,644 Loss from operations $ (756) $ (254) $ (980) $ (1,990) Interest and other expense, net 5 90 — 95 Net loss before taxes $ (761) $ (344) $ (980) $ (2,085) Income tax $ — $ — $ — $ — Net loss $ (761) $ (344) $ (980) $ (2,085) Nine Months Ended September 30, 2020 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 4,741 $ 6,669 $ — $ 11,410 Cost of revenues 2,948 2,736 — 5,684 Gross profit $ 1,793 $ 3,933 $ — $ 5,726 Gross profit % 38 % 59 % 50 % Allocated operating expenses $ 3,398 $ 7,545 $ — $ 10,943 Unallocated operating expenses — — 3,059 3,059 Total operating expenses $ 3,398 $ 7,545 $ 3,059 $ 14,002 Loss from operations $ (1,605) $ (3,612) $ (3,059) $ (8,276) Interest and other expense, net 12 310 — 322 Net loss before tax $ (1,617) $ (3,922) $ (3,059) $ (8,598) Income tax — — — — Net loss (1,617) (3,922) $ (3,059) $ (8,598) Concentration of revenues was as follows: Three Months Ended September 30, 2021 2020 Segment % of Revenue % of Revenue Customer A Oblong (formerly Glowpoint) 37 % 23 % Customer B Oblong Industries — % 20 % Nine Months Ended September 30, 2021 2020 Segment % of Revenue % of Revenue Customer A Oblong (formerly Glowpoint) 35 % 23 % Customer B Oblong Industries — % 27 % Concentration of accounts receivable was as follows: As of September 30, 2021 2020 Segment % of Accounts Receivable % of Accounts Receivable Customer A Oblong (formerly Glowpoint) 17 % 20 % Customer B Oblong (formerly Glowpoint) — % 15 % Customer C Oblong Industries 12 % — % Customer D Oblong Industries 11 % — %
Revenue from External Customers by Geographic Areas	Revenue by geographic area is allocated as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Domestic $ 1,035 $ 2,080 $ 3,277 $ 7,536 Foreign 764 1,186 2,489 3,874 $ 1,799 $ 3,266 $ 5,766 $ 11,410
Schedule of Disaggregated Revenue Information	Disaggregated information for the Company’s revenue has been recognized in the accompanying condensed consolidated statements of operations and is presented below according to contract type (in thousands): Three Months Ended September 30, 2021 % of Revenue 2020 % of Revenue Revenue: Oblong (formerly Glowpoint) Video collaboration services $ 179 10 % $ 249 8 % Network services 813 45 % 1,028 31 % Professional and other services 14 1 % 47 1 % Total Oblong (formerly Glowpoint) revenue $ 1,006 56 % $ 1,324 40 % Revenue: Oblong Industries Visual collaboration product offerings $ 771 43 % 1,686 52 % Licensing 22 1 % 256 8 % Total Oblong Industries revenue $ 793 44 % 1,942 60 % Total revenue $ 1,799 100 % $ 3,266 100 % Nine Months Ended September 30, 2021 % of Revenue 2020 % of Revenue Revenue: Oblong (formerly Glowpoint) Video collaboration services $ 700 12 % $ 1,722 15 % Network services 2,524 44 % 2,844 25 % Professional and other services 55 1 % 175 2 % Total Oblong (formerly Glowpoint) revenue $ 3,279 57 % $ 4,741 42 % Revenue: Oblong Industries Visual collaboration product offerings $ 2,406 42 % 4,931 43 % Professional services — — % 898 8 % Licensing 81 1 % 840 7 % Total Oblong Industries revenue $ 2,487 43.13 % 6,669 58 % Total revenue $ 5,766 100 % $ 11,410 100 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Balance Sheet Information	The following provides balance sheet information related to leases were as follows (in thousands): September 30, 2021 Assets Operating lease, right-of-use asset, net $ 531 Liabilities Current portion of operating lease liabilities $ 475 Operating lease liabilities, net of current portion 182 Total operating lease liabilities $ 657
Schedule of Future Minimum Rental Payments for Operating Leases	The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments Remainder of 2021 $ 189 2022 379 2023 116 Total lease payments $ 684 Effect of discounting (27) Total operating lease liabilities $ 657

Business Description and Sign_3

Business Description and Significant Accounting Policies (Details) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2021USD ($)segment	Sep. 30, 2020USD ($)
Accounting Policies [Abstract]
Number of operating segments | segment		2
Property, Plant and Equipment [Line Items]
Impairment charges - property and equipment | $	$ 50	$ 98	$ 126
Minimum
Property, Plant and Equipment [Line Items]
Useful lives		3 years
Maximum
Property, Plant and Equipment [Line Items]
Useful lives		10 years

Liquidity and Going Concern U_2

Liquidity and Going Concern Uncertainty (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 10,734			$ 2,670			$ 10,734	$ 2,670	$ 5,058
Working capital	12,410						12,410
Net loss	$ 662	$ 2,246	$ 3,433	$ 2,085	$ 3,385	$ 3,129	6,341	8,598
Net cash used in operating activities							$ 5,956	$ 4,325

Goodwill - Narrative (Details)

Goodwill - Narrative (Details)	9 Months Ended
	Sep. 30, 2021USD ($)segment	Sep. 30, 2020USD ($)	Dec. 31, 2020USD ($)
Goodwill [Line Items]
Goodwill	$ 7,367,000		$ 7,367,000
Number of reporting units | segment	2
Impairment charges - goodwill	$ 0	$ 541,000
Oblong Industries
Goodwill [Line Items]
Impairment charges - goodwill	$ 0

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Business Acquisition [Line Items]
Gross Carrying Amount	$ 13,774	$ 13,774		$ 13,774
Accumulated Amortization	(5,425)	(5,425)		(3,634)
Impairment		(207)	$ 0
Net Carrying Amount	8,142	8,142		10,140
Oblong (formerly Glowpoint) | Affiliate network
Business Acquisition [Line Items]
Gross Carrying Amount	994	994		994
Accumulated Amortization	(787)	(787)		(735)
Impairment	(207)	(207)
Net Carrying Amount	0	0		259
Oblong Industries
Business Acquisition [Line Items]
Gross Carrying Amount	12,780	12,780		12,780
Accumulated Amortization	(4,638)	(4,638)		(2,899)
Impairment		0
Net Carrying Amount	8,142	8,142		9,881
Oblong Industries | Developed technology
Business Acquisition [Line Items]
Gross Carrying Amount	10,060	10,060		10,060
Accumulated Amortization	(4,032)	(4,032)		(2,520)
Impairment		0
Net Carrying Amount	6,028	$ 6,028		7,540
Estimated Useful Life		5 years
Oblong Industries | Trade names
Business Acquisition [Line Items]
Gross Carrying Amount	2,410	$ 2,410		2,410
Accumulated Amortization	(482)	(482)		(302)
Impairment		0
Net Carrying Amount	1,928	$ 1,928		2,108
Estimated Useful Life		10 years
Oblong Industries | Distributor relationships
Business Acquisition [Line Items]
Gross Carrying Amount	310	$ 310		310
Accumulated Amortization	(124)	(124)		(77)
Impairment		0
Net Carrying Amount	$ 186	$ 186		$ 233
Estimated Useful Life		5 years

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Business Acquisition [Line Items]
Impairment charges - intangible assets			$ 207	$ 0
Amortization expense	$ 597	$ 1,791	611	$ 1,835
Affiliate network | Oblong (formerly Glowpoint)
Business Acquisition [Line Items]
Impairment charges - intangible assets	$ 207		$ 207
Minimum
Business Acquisition [Line Items]
Intangible assets, estimated useful life			5 years
Maximum
Business Acquisition [Line Items]
Intangible assets, estimated useful life			12 years

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2021	$ 580
2022	2,316
2023	2,309
2024	1,792
2025	241
Thereafter	904
Net Carrying Amount	$ 8,142	$ 10,140

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Other Liabilities Disclosure [Abstract]
Accrued compensation costs	$ 421	$ 411
Accrued professional fees	208	236
Accrued taxes and regulatory fees	172	137
Customer deposits	51	127
Other accrued expenses and liabilities	138	286
Accrued dividends on Series A-2 Preferred Stock	0	4
Accrued expenses and other current liabilities	$ 990	$ 1,201

Debt - Schedule of Long-term De

Debt - Schedule of Long-term Debt (Details) - USD ($)	Sep. 30, 2021	Jul. 28, 2021	Dec. 31, 2020	Apr. 10, 2020
Debt Instrument [Line Items]
Less: current portion of long-term debt	$ 0		$ 2,014,000
PPP Loan
Debt Instrument [Line Items]
PPP Loan Principal	0	$ 2,417,000	2,417,000	$ 2,417,000
Less: current portion of long-term debt	0		2,014,000
Long-term debt, net of current portion	$ 0		$ 403,000

Debt - Paycheck Protection Prog

Debt - Paycheck Protection Program Loan (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Jul. 28, 2021	Dec. 31, 2020	Apr. 10, 2020
Debt Instrument [Line Items]
Gain on extinguishment of debt	$ 2,448,000	$ 0	$ 2,448,000	$ 0
PPP Loan
Debt Instrument [Line Items]
Long term debt	0		0		$ 2,417,000	$ 2,417,000	$ 2,417,000
Fixed rate							1.00%
Gain on extinguishment of debt	$ 2,448,000		$ 2,448,000
Interest accrued					$ 31,000

Capital Stock - Common Stock (D

Capital Stock - Common Stock (Details) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Equity [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	30,929,331	7,861,912
Common stock, shares outstanding (in shares)	30,816,048	7,748,629

Capital Stock - Additional Info

Capital Stock - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands

Jun. 30, 2021

Jan. 21, 2021

Dec. 10, 2020

Dec. 06, 2020

Oct. 21, 2020

Oct. 01, 2019

Jun. 30, 2021

Mar. 31, 2021

Sep. 30, 2020

Mar. 31, 2020

Sep. 30, 2021

Sep. 30, 2020

Dec. 31, 2020

Dec. 31, 2019

Class of Stock [Line Items]

Conversion of convertible preferred stock, shares (in shares)

1,315,790

Issuance of stock for services

$ 116

$ 274

Issuance costs

$ 896

Proceeds from stock issuance, net of issuance costs

$ 11,504

$ 11,504

$ 0

Issuance of common shares from warrant exercise (in shares)

521,500

Warrant term

2 years

Exercise price (in dollars per share)

$ 4.42

$ 4.85

$ 0.01

Warrant exercises

0

General and administrative expense

Class of Stock [Line Items]

Stock option compensation expense

$ 390

Warrants

Class of Stock [Line Items]

Issuance of common shares from warrant exercise (in shares)

625,000

Warrant term

2 years

Exercise price (in dollars per share)

$ 5.49

$ 4.08

Warrants | Public Offering

Class of Stock [Line Items]

Number of shares issued (in shares)

1,000,000

Warrants | Private Placement

Class of Stock [Line Items]

Number of shares issued (in shares)

3,000,000

Common Stock

Class of Stock [Line Items]

Conversion of convertible preferred stock, shares (in shares)

25,000

50,000

18,846,411

75,000

Shares issued for stock based compensation (in shares)

200,000

23,334

Issuance of shares for professional service fees (in shares)

21,008

50,000

21,008

Issuance of stock for services

$ 100

$ 348

Common Stock | Public Offering

Class of Stock [Line Items]

Number of shares issued (in shares)

4,000,000

Sale of stock, price per share (in dollars per share)

$ 4

Common Stock | Private Placement

Class of Stock [Line Items]

Sale of stock, price per share (in dollars per share)

$ 4.40

Proceeds from issuance of common stock gross

$ 12,400

Series A Warrants

Class of Stock [Line Items]

Warrant term

6 months

Series B Warrants

Class of Stock [Line Items]

Warrant term

3 years

Capital Stock - Warrants Activi

Capital Stock - Warrants Activity (Details) - $ / shares shares in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Number of Warrants (in thousands)
Warrants outstanding and exercisable, Beginning (in shares)	1,147	72
Granted (in shares)	4,000	1,147
Exercised (in shares)		(72)
Warrants outstanding and exercisable, Ending (in shares)	5,147	1,147
Weighted Average Exercise Price
Warrants outstanding and exercisable, Beginning (in dollars per share)	$ 4.85	$ 0.01
Granted, (in dollars per share)	4.30	4.85
Exercised, (in dollars per share)		0.01
Warrants outstanding and exercisable, Ending (in dollars per share)	$ 4.42	$ 4.85

Capital Stock - Equity Activity

Capital Stock - Equity Activity (Details) - USD ($) $ in Thousands	3 Months Ended					12 Months Ended
	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	$ 28,305	$ 22,057	$ 15,407	$ 18,775	$ 21,785	$ 21,785
Purchases to cover stock compensation taxes	502	33	27	29	32
Ending Balance	$ 28,145	$ 18,931	$ 13,345	$ 15,407	$ 18,775	$ 22,057
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	113,283	113,283	113,283	105,285	105,285	105,285
Beginning Balance	$ (181)	$ (181)	$ (181)	$ (172)	$ (165)	$ (165)
Purchases to cover stock compensation taxes (in shares)						8,000
Purchases to cover stock compensation taxes						$ (16)
Ending Balance (in shares)	113,283	113,283	113,283	113,283	105,285	113,283
Ending Balance	$ (181)	$ (181)	$ (181)	$ (181)	$ (172)	$ (181)

Preferred Stock (Details)

Preferred Stock (Details) - USD ($)	Jan. 28, 2021	Oct. 01, 2019	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)							5,000,000
Preferred stock designated share							1,941,250
Preferred stock, shares issued (in shares)							0
Preferred stock, shares outstanding (in shares)							0		1,829,582
Accrued dividends on Series A-2 Preferred Stock							$ 0		$ 4,000
Dividends							$ 1,000
Preferred stock conversion	$ 300,000
Conversion of convertible preferred stock, shares (in shares)		1,315,790
Common Stock
Class of Stock [Line Items]
Shares issued in conversion (in shares)	84,292								20,954
Conversion of convertible preferred stock, shares (in shares)				25,000		50,000	18,846,411	75,000
Issuance of restricted stock (in shares)					23,334
Restricted stock
Class of Stock [Line Items]
Vesting period							10 years
Series A-2 Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)							7,500		7,500
Preferred stock, shares issued (in shares)							0		45
Preferred stock, shares outstanding (in shares)	45						0		45
Preferred stock, stated value							$ 7,500		$ 7,500
Stock issued during period, conversion of convertible securities, price (in dollars per share)	$ 4								$ 16.11
Preferred stock percentage			5.00%
Series A-2 Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)			(45)
Series A-2 Preferred Stock | Common Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)									466
Conversion of convertible preferred stock, shares (in shares)			84,292
Series D Convertible Preferred Stock | Common Stock
Class of Stock [Line Items]
Preferred stock, shares outstanding (in shares)		17,416,939
Series D Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)							1,750,000		1,750,000
Preferred stock, shares issued (in shares)							0		1,697,958
Preferred stock, shares outstanding (in shares)							0		1,697,958
Preferred stock, stated value							$ 28.50		$ 28.50
Shares issued in conversion (in shares)		1,697,022
Preferred stock percentage		6.00%
Conversion of convertible preferred stock, shares (in shares)		1,686,659
Forfeited, restricted shares (in shares)			81						28,618
Series D Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)			855						8,325
Conversion of convertible preferred stock, shares (in shares)			(1,697,022)
Series D Preferred Stock | Restricted stock
Class of Stock [Line Items]
Issuance of restricted stock (in shares)		49,967
Vesting period		2 years
Forfeited, restricted shares (in shares)				1,086			81	32,891
Series E Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)							175,000		175,000
Preferred stock, shares issued (in shares)							0		131,579
Preferred stock, shares outstanding (in shares)		131,579					0		131,579
Preferred stock, stated value		$ 28.50					$ 28.50		$ 28.50
Shares issued in conversion (in shares)		131,579
Preferred stock percentage		6.00%
Series E Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)			(131,579)
Series E Preferred Stock | Common Stock
Class of Stock [Line Items]
Preferred stock, shares outstanding (in shares)		1,345,180
Series E Preferred Stock | Series E Financing
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)		131,579
Stock issued during period, conversion of convertible securities, price (in dollars per share)		$ 2.85
Sale of stock consideration received		$ 3,750,000
Sale of stock, price per share (in dollars per share)		$ 2.85

Stock Based Compensation - Narr

Stock Based Compensation - Narrative (Details) - USD ($)	Aug. 18, 2021	Jun. 28, 2021	Oct. 01, 2019	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted (in shares)							300,000
Outstanding Weighted Average Exercise Price, Granted (in dollars per share)							$ 3.25
Unrecognized stock-based compensation expense for stock options				$ 681,000			$ 681,000
2019 Equity incentive plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)				2,513,500			2,513,500
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense				$ 64,000				$ 0
Unrecognized stock-based compensation expense for stock options, period							2 years 9 months
Stock options | Share-based Payment Arrangement, Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted (in shares)		300,000							0
Vesting period		3 years
Exercise period		10 years
Outstanding Weighted Average Exercise Price, Granted (in dollars per share)		$ 3.25
Share-based compensation vested in period, fair Value		$ 745,000
Stock options | Share-based Payment Arrangement, Employee | Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							33.00%
Stock options | Share-based Payment Arrangement, Employee | Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							33.00%
Stock options | Share-based Payment Arrangement, Employee | Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							33.00%
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							10 years
Stock option compensation expense				$ 0		$ 0	$ 0	$ 0
Award service period							5 years
Granted, weighted average grant price (in dollars per share)							$ 15.80	$ 15.80
Unvested restricted shares outstanding (in shares)				627		627	627	627
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation arrangement, vested in period, remain outstanding (in shares)							28,904
Unrecognized stock-based compensation expense for other than options				$ 0			$ 0
Unvested restricted shares outstanding (in shares)				0			0
RSUs | Nonemployee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, restricted shares (in shares)	200,000
Granted, weighted average grant price (in dollars per share)	$ 2.19
RSUs | Share-based Payment Arrangement, Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense								$ 6,000
Granted, restricted shares (in shares)									0
Share-based compensation arrangement by share-based payment award, grand value in period							$ 438,000
Series D Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Forfeited, restricted shares (in shares)					81				28,618
Series D Preferred Stock | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			2 years
Stock option compensation expense				$ 0		$ 28,000	33,000	$ 83,000
Issuance of restricted stock (in shares)			49,967
Unrecognized stock-based compensation expense for other than options				$ 0			$ 0
Forfeited, restricted shares (in shares)						1,086	81	32,891
Unvested restricted shares outstanding (in shares)				0			0

Stock Based Compensation - Para

Stock Based Compensation - Parameters of Fair Value Calculation (Details)	Jun. 28, 2021$ / shares
Share-based Payment Arrangement [Abstract]
Risk free interest rate	0.47%
Expected maturity	3 years
Expected volatility	136.00%
Expected dividend yields	0.00%
Weighted average grant date fair value per share	$ 2.48

Stock Based Compensation - Opti

Stock Based Compensation - Options Outstanding (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Number of Options
Outstanding Number of Options, Beginning (in shares)	107,500	215,345
Expired (in shares)		(107,845)
Number of options granted (in shares)	300,000
Outstanding Number of Options, Ending (in shares)	407,500	107,500
Weighted Average Exercise Price
Outstanding Weighted Average Exercise Price, Beginning (in dollars per share)	$ 19.64	$ 12.27
Outstanding Weighted Average Exercise Price, Expired (in dollars per share)		4.92
Outstanding Weighted Average Exercise Price, Granted (in dollars per share)	3.25
Outstanding and Exercisable Weighted Average Exercise Price, Ending (in dollars per share)	$ 7.57	$ 19.64
Exercisable
Exercisable Number of Options (in shares)	107,500	107,500	215,345
Exercisable Weighted Average Exercise Price (in dollars per share)	$ 19.64	$ 19.64	$ 12.27

Stock Based Compensation - Exer

Stock Based Compensation - Exercise Price Range (Details) - $ / shares	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options, Outstanding (in shares)	407,500	107,500	215,345
Weighted Average Remaining Contractual Life (In Years)	7 years 6 months 3 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 7.57	$ 19.64	$ 12.27
Number of Options, Exercisable (in shares)	107,500	107,500	215,345
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 19.64	$ 19.64	$ 12.27
$0.00 – $10.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	0
Range of price, upper range limit (in dollars per share)	$ 10
Number of Options, Outstanding (in shares)	302,500
Weighted Average Remaining Contractual Life (In Years)	9 years 8 months 4 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 3.30
Number of Options, Exercisable (in shares)	2,500
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 9
$10.01 – $20.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	10.01
Range of price, upper range limit (in dollars per share)	$ 20
Number of Options, Outstanding (in shares)	97,500
Weighted Average Remaining Contractual Life (In Years)	1 year 3 months 21 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 19.32
Number of Options, Exercisable (in shares)	97,500
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 19.32
$20.01 – $30.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	20.01
Range of price, upper range limit (in dollars per share)	$ 30
Number of Options, Outstanding (in shares)	2,500
Weighted Average Remaining Contractual Life (In Years)	8 months 4 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 21.80
Number of Options, Exercisable (in shares)	2,500
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 21.80
$30.01 – $40.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	30.01
Range of price, upper range limit (in dollars per share)	$ 40
Number of Options, Outstanding (in shares)	5,000
Weighted Average Remaining Contractual Life (In Years)	5 months 12 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 30.20
Number of Options, Exercisable (in shares)	5,000
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 30.20

Stock Based Compensation - Stoc

Stock Based Compensation - Stock Compensation Expense, Restricted Stock Units (Details) - Restricted stock - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 0	$ 0	$ 0	$ 0
Series D Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	28,000	33,000	83,000
Series D Preferred Stock | Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	11,000	17,000	39,000
Series D Preferred Stock | Sales, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 0	$ 17,000	$ 16,000	$ 44,000

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details)	9 Months Ended
	Sep. 30, 2021shares
Earnings Per Share [Abstract]
Weighted-average shares common stock outstanding, potentially dilutive securities or unvested restricted stock (in shares)	0

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator:
Net loss	$ (662)	$ (2,246)	$ (3,433)	$ (2,085)	$ (3,385)	$ (3,129)	$ (6,341)	$ (8,598)
Less: preferred stock dividends	0			(4)			(1)	(12)
Less: undeclared dividends	0			0			(366)	0
Induced conversion of Series A-2 Preferred Stock	0			0			(300)	0
Net loss attributable to common stockholders	(662)			(2,089)			(7,008)	(8,610)
Net loss attributable to common stockholders	$ (662)			$ (2,089)			$ (7,008)	$ (8,610)
Denominator:
Weighted-average number of shares of common stock for basic net loss per share (in shares)	30,739,000			5,257,000			25,121,000	5,237,000
Weighted-average number of shares of common stock for diluted net loss per share (in shares)	30,739,000			5,257,000			25,121,000	5,237,000
Basic net loss per share (in dollars per share)	$ (0.02)			$ (0.40)			$ (0.28)	$ (1.64)
Diluted net loss per share (in dollars per share)	$ (0.02)			$ (0.40)			$ (0.28)	$ (1.64)

Net Loss Per Share - Effect of

Net Loss Per Share - Effect of Antidilutive Securities (Details) - shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	407,500	107,500
Unvested restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	627	627
Series A-2 Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	15,545
Series C Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	83,333
Series D Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	17,030,960
Series E Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	1,315,790
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	5,146,500	72,394

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021USD ($)	Jun. 30, 2021USD ($)	Mar. 31, 2021USD ($)	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Sep. 30, 2021USD ($)segment	Sep. 30, 2020USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment							2
Revenue	$ 1,799			$ 3,266			$ 5,766	$ 11,410
Cost of revenues	1,228			1,612			3,767	5,684
Gross profit	$ 571			$ 1,654			$ 1,999	$ 5,726
Gross profit %	32.00%			51.00%			35.00%	50.00%
Total operating expenses	$ 3,682			$ 3,644			$ 10,999	$ 14,002
Income (loss) from operations	(3,111)			(1,990)			(9,000)	(8,276)
Interest and other expense (income), net	(2,449)			95			(2,659)	322
Loss before income taxes	(662)			(2,085)			(6,341)	(8,598)
Income tax expense	0			0			0	0
Net loss	(662)	$ (2,246)	$ (3,433)	(2,085)	$ (3,385)	$ (3,129)	(6,341)	(8,598)
Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	2,054			2,664			5,921	10,943
Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	1,628			980			5,078	3,059
Oblong (formerly Glowpoint)
Segment Reporting Information [Line Items]
Revenue	1,006			1,324			3,279	4,741
Cost of revenues	721			893			2,293	2,948
Gross profit	$ 285			$ 431			$ 986	$ 1,793
Gross profit %	28.00%			33.00%			30.00%	38.00%
Total operating expenses	$ 337			$ 1,187			$ 527	$ 3,398
Income (loss) from operations	(52)			(756)			459	(1,605)
Interest and other expense (income), net	2			5			16	12
Loss before income taxes	(54)			(761)			443	(1,617)
Income tax expense	0			0			0	0
Net loss	(54)			(761)			443	(1,617)
Oblong (formerly Glowpoint) | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	337			1,187			527	3,398
Oblong (formerly Glowpoint) | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0			0				0
Oblong Industries
Segment Reporting Information [Line Items]
Revenue	793			1,942			2,487	6,669
Cost of revenues	507			719			1,474	2,736
Gross profit	$ 286			$ 1,223			$ 1,013	$ 3,933
Gross profit %	36.00%			63.00%			41.00%	59.00%
Total operating expenses	$ 1,717			$ 1,477			$ 5,394	$ 7,545
Income (loss) from operations	(1,431)			(254)			(4,381)	(3,612)
Interest and other expense (income), net	(3)			90			(227)	310
Loss before income taxes	(1,428)			(344)			(4,154)	(3,922)
Income tax expense	0			0			0	0
Net loss	(1,428)			(344)			(4,154)	(3,922)
Oblong Industries | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	1,717			1,477			5,394	7,545
Oblong Industries | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0			0				0
Corporate
Segment Reporting Information [Line Items]
Revenue	0			0			0	0
Cost of revenues	0			0			0	0
Gross profit	0			0			0	0
Total operating expenses	1,628			980			5,078	3,059
Income (loss) from operations	(1,628)			(980)			(5,078)	(3,059)
Interest and other expense (income), net	(2,448)			0			(2,448)	0
Loss before income taxes	820			(980)			(2,630)	(3,059)
Income tax expense	0			0			0	0
Net loss	820			(980)			(2,630)	(3,059)
Corporate | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0			0			0	0
Corporate | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	$ 1,628			$ 980			$ 5,078	$ 3,059

Segment Reporting - Disaggregat

Segment Reporting - Disaggregation of Revenue and Total Assets (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)
Disaggregation of Revenue [Line Items]
Foreign revenue	0.01	0.01	0.01	0.01
Revenue	$ 1,799	$ 3,266	$ 5,766	$ 11,410
Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 1,799	$ 3,266	$ 5,766	$ 11,410
Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	100.00%	100.00%	100.00%	100.00%
Oblong (formerly Glowpoint)
Disaggregation of Revenue [Line Items]
Revenue	$ 1,006	$ 1,324	$ 3,279	$ 4,741
Oblong (formerly Glowpoint) | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 1,006	$ 1,324	$ 3,279	$ 4,741
Oblong (formerly Glowpoint) | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	56.00%	40.00%	57.00%	42.00%
Oblong (formerly Glowpoint) | Video collaboration services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 179	$ 249	$ 700	$ 1,722
Oblong (formerly Glowpoint) | Video collaboration services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	10.00%	8.00%	12.00%	15.00%
Oblong (formerly Glowpoint) | Network services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 813	$ 1,028	$ 2,524	$ 2,844
Oblong (formerly Glowpoint) | Network services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	45.00%	31.00%	44.00%	25.00%
Oblong (formerly Glowpoint) | Professional and other services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 14	$ 47	$ 55	$ 175
Oblong (formerly Glowpoint) | Professional and other services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	1.00%	1.00%	1.00%	2.00%
Oblong Industries
Disaggregation of Revenue [Line Items]
Revenue	$ 793	$ 1,942	$ 2,487	$ 6,669
Oblong Industries | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 793	$ 1,942	$ 2,487	$ 6,669
Oblong Industries | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	44.00%	60.00%	43.13%	58.00%
Oblong Industries | Video collaboration services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 771	$ 1,686	$ 2,406	$ 4,931
Oblong Industries | Video collaboration services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	43.00%	52.00%	42.00%	43.00%
Oblong Industries | Professional and other services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue			$ 0	$ 898
Oblong Industries | Professional and other services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue			0.00%	8.00%
Oblong Industries | Licensing | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 22	$ 256	$ 81	$ 840
Oblong Industries | Licensing | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	1.00%	8.00%	1.00%	7.00%
Domestic
Disaggregation of Revenue [Line Items]
Revenue	$ 1,035	$ 2,080	$ 3,277	$ 7,536
Foreign
Disaggregation of Revenue [Line Items]
Revenue	$ 764	$ 1,186	$ 2,489	$ 3,874

Segment Reporting - Concentrati

Segment Reporting - Concentration Percentage (Details) - Customer Concentration Risk	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Customer A | Oblong (formerly Glowpoint) | Revenue
Concentration Risk [Line Items]
Concentration risk, percentage	37.00%	23.00%	35.00%	23.00%
Customer A | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage			17.00%	20.00%
Customer B | Oblong Industries | Revenue
Concentration Risk [Line Items]
Concentration risk, percentage	0.00%	20.00%	0.00%	27.00%
Customer B | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage			0.00%	15.00%
Customer C | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage			12.00%	0.00%
Customer D | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage			11.00%	0.00%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) € in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021EUR (€)facility	Sep. 30, 2021USD ($)facility	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)facility
Lessee, Lease, Description [Line Items]
Operating lease liability | $						$ 657
Non-cash lease expense | $	$ 85	$ 267		$ 252	$ 915
Los Angeles, California
Lessee, Lease, Description [Line Items]
Number of facilities			3	3
Number of facilities occupied			2			2
Boston, Massachusetts
Lessee, Lease, Description [Line Items]
Number of facilities			1	1
Dallas, Texas
Lessee, Lease, Description [Line Items]
Number of facilities			1	1
Munich, Germany
Lessee, Lease, Description [Line Items]
Contract termination fee | €			€ 125
Operating lease liability | €			316
Termination of lease			€ 191	$ 227
Minimum
Lessee, Lease, Description [Line Items]
Term of contract			1 year			1 year
Renewal term			12 months			12 months
Maximum
Lessee, Lease, Description [Line Items]
Term of contract			3 years			3 years
Renewal term			5 years			5 years

Commitments and Contingencies_2

Commitments and Contingencies - Balance Sheet Information (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Operating lease, right-of-use asset, net	$ 531	$ 903
Current portion of operating lease liabilities	475	830
Operating lease liabilities, net of current portion	182	$ 602
Total operating lease liabilities	$ 657

Commitments and Contingencies_3

Commitments and Contingencies - Table Operating Lease Future Minimum Rental Commitment (Details) $ in Thousands	Sep. 30, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of 2021	$ 189
2022	379
2023	116
Total lease payments	684
Effect of discounting	(27)
Total operating lease liabilities	$ 657

Related Party (Details)

Related Party (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)
Bolster | Fractional Labor
Related Party Transaction [Line Items]
Related party expense	$ 31